The use of cangrelor in neurovascular interventions: a multicenter experience-Reference-Cited by-同舟云学术

The use of cangrelor in neurovascular interventions: a multicenter experience

Published:2020-11-11 Issue:6 Volume:63 Page:925-934
ISSN:0028-3940
Container-title:Neuroradiology
language:en
Short-container-title:Neuroradiology

Author:

Cortez Gustavo M.,Monteiro André,Sourour Nader,Clarençon Frédéric,Elhorany Mahmoud,Grigoryan Mikayel,Mirza Soz,Dabus Guilherme,Linfante Italo,Aguilar-Salinas Pedro,Murtaza Yasmeen,Aghaebrahim Amin,Sauvageau Eric,Hanel Ricardo A.^ORCID

Funder

Chiesi Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Neurology (clinical),Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00234-020-02599-2.pdf

Reference39 articles.

1. Fiorella D (2010) Anti-thrombotic medications for the neurointerventionist: aspirin and clopidogrel. J Neurointerv Surg 2(1):44–49. https://doi.org/10.1136/jnis.2009.001859

2. Nishi H, Nakahara I, Matsumoto S, Hashimoto T, Ohta T, Sadamasa N, Ishibashi R, Gomi M, Saka M, Miyata H, Watanabe S, Okata T, Sonoda K, Kouge J, Ishii A, Nagata I, Kira J (2016) Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy. J Neurointerv Surg 8(9):949–953. https://doi.org/10.1136/neurintsurg-2015-011844

3. Tapp L, Shantsila E, Lip GY (2010) Role of ticagrelor in clopidogrel nonresponders: resistance is futile? Circulation 121(10):1169–1171. https://doi.org/10.1161/CIR.0b013e3181d8d929

4. Delgado Almandoz JE, Kadkhodayan Y, Crandall BM, Scholz JM, Fease JL, Tubman DE (2014) Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms. J Neurointerv Surg 6(10):767–773. https://doi.org/10.1136/neurintsurg-2013-010976

5. Sibbing D, Aradi D, Alexopoulos D, Ten Berg J, Bhatt DL, Bonello L, Collet JP, Cuisset T, Franchi F, Gross L, Gurbel P, Jeong YH, Mehran R, Moliterno DJ, Neumann FJ, Pereira NL, Price MJ, Sabatine MS, So DYF, Stone GW, Storey RF, Tantry U, Trenk D, Valgimigli M, Waksman R, Angiolillo DJ (2019) Updated expert consensus statement on platelet function and genetic testing for guiding P2Y(12) receptor inhibitor treatment in percutaneous coronary intervention. JACC Cardiovasc Interv 12(16):1521–1537. https://doi.org/10.1016/j.jcin.2019.03.034

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Un anticorps monoclonal ciblant la glycoprotéine VI plaquettaire : une nouvelle génération d’antithrombotique sans risque hémorragique à la phase aiguë de l’infarctus cérébral;Bulletin de l'Académie Nationale de Médecine;2024-08

2. Cangrelor for neurointerventional procedures: A systematic review;Interventional Neuroradiology;2024-04-13

3. Intravenous cangrelor use for neuroendovascular procedures: a two-center experience and updated systematic review;Frontiers in Neurology;2023-12-05

4. Low dose intravenous cangrelor versus glycoprotein IIb/IIIa inhibitors in endovascular treatment of tandem lesions;Journal of Stroke and Cerebrovascular Diseases;2023-12

5. Efficacy and safety of low dose intravenous cangrelor in a consecutive cohort of patients undergoing neuroendovascular procedures;Journal of NeuroInterventional Surgery;2023-03-15